A wide variety of signaling molecules secreted by cancer cells and cell components within TME have been identified as important players in tumor angiogenesis, among which the vascular endothelial growth factor (VEGF), extracellular proteases, chemokines and cytokines are important targets for anti-angiogenic therapy in breast cancer. The gene discussed is VEGFA; the disease is cancer.